Company intelligence
GATC Health
Using advanced AI to make drug development faster, safer, and more accurate.
About GATC Health
GATC Health is a tech-bio company revolutionizing drug discovery and development by simulating complex human biology to predict how drugs will perform in the body, achieving 91% specificity and 86% sensitivity. Trusted by the world’s largest insurance marketplace, biopharma, researchers, and investment partners, GATC Health’s risk prediction product, the Derisq™ AI report, accurately assesses and predicts drug candidate safety, efficacy, and non-obvious side effects prior to the commitment of development capital. GATC Health’s AI platform, Operon™, is also generative, creating intellectual property, extending pipelines, and optimizing assets. By uniting advanced AI, multiomics, and predictive modeling, GATC Health accelerates breakthroughs and reduces costly late-stage failures to bring safer, more effective therapies to patients worldwide. For more information, visitgatchealth.com.
Verified activity
Signals from GATC Health
2 published signals
Presence & Recognition
GATC Health President Dr. Rahul Gupta is speaking at the VI Congreso de Cadena de Abastecimiento and XII Congreso de Servicios Farmacéuticos in Barranquilla, Colombia.
Reported by GATC Health
Partnerships
GATC Health and DnaK Therapeutics announced a collaboration to use GATC’s proprietary artificial intelligence platform to evaluate and prioritize 16 innovative, potential cancer drug candidates.
Reported by GATC Health